March Biosciences
PrivateLast Round
Series A
Oct 23, 2024
Est. Valuation
$47M
Total Funding Raised
$45.88M
Company Overview
March Biosciences is a biotechnology company that develops CAR-T cell therapies for the treatment of hematological cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
March Biosciences Comparables
Compare March Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allotera Therapeutics | 78% | |
| Beam Therapeutics | 74% | |
| Roche Holding | 74% | |
March Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 23, 2024 | ||||
| Grant | Sep 1, 2024 | ||||
| Grant | Nov 15, 2023 | ||||
| VC Round | Nov 9, 2023 | ||||
| Seed | Jun 26, 2023 |
Key People
Founding team and executive leadership
March Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| 4BIO Capital | Series A |
| The University of Texas MD Anderson Cancer Center | VC Round, Series A |
| CANCER FUND | Series A |
| Texas Medical Center Venture Fund | Seed |
| Cancer Focus Fund | Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Grew 19% QoQ, from 21 to 25 employees.
- Sep 1, 2024
Secured $1.1M from National Cancer Institute and NIH RADx.
March Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about March Biosciences's valuation, stock price, and market status.